HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Conditions: Human Papillomavirus Type 16; Cervical Intraepithelial Neoplasia Grade II; Cervical Intraepithelial Neoplasia, Grade III Intervention: Drug: pNGVL4aCRTE6E7L2 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials